P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

Autor: I. Attucci, S. Pilerci, S. Bonifacio, L. Pengue, A. Buzzichelli, M. Messeri, AM Vannucchi, E. Antonioli

Publikováno v: HemaSphere, Vol 7, Iss S2, Pp 22-22 (2023)

Externí odkaz: https://doaj.org/article/7301796cc360418f9cf91d63a7a00fca

In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor

Autor: AM Vannucchi, A Grossi, D Rafanelli, PR Ferrini

Publikováno v: Blood. 76:1473-1480

Murine recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) was injected in mice, and the effects on bone marrow, splenic megakaryocytes, megakaryocyte precursors (megakaryocyte colony-forming units [CFU-Meg]) were evaluated. In mic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c512111a898e240028ae54862bcfa63
https://doi.org/10.1182/blood.v76.8.1473.bloodjournal7681473

[GM-CSF: its clinical administration; the treatment of aplasia]

Autor: Rossi Ferrini P, Grossi A, VALERIA SANTINI, Am, Vannucchi

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::002003a7639bc012217488d8781a1921
http://europepmc.org/abstract/med/2512231

When and how to transplant in myelofibrosis - recent trends.

Autor: Sharma N; Department of Hematology and Oncology, University of Massachusetts-Baystate Medical Center, Springfield, MA, USA., Loscocco GG; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Gangat N; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Pardanani A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Alkhateeb HB; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Ho VT; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov 14, pp. 1-19. Date of Electronic Publication: 2024 Nov 14.

Hepatoid thymic carcinoma in a polycythemia vera patient treated with ropeginterferon Alfa-2b: Clinical, histopathological and molecular correlates.

Autor: Loscocco GG; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Vannucchi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Santi R; Pathology Section, Department of Health Sciences, University of Florence, Florence, Italy., Amorosi A; Department of Health Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy., Scarpino S; Department of Clinical and Molecular Medicine, Sapienza University, Sant'Andrea Hospital, Rome, Italy., Siciliano MC; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Guglielmelli P; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy; IFOM-ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Di Napoli A; Department of Clinical and Molecular Medicine, Sapienza University, Sant'Andrea Hospital, Rome, Italy., Vannucchi AM; Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy. Electronic address: amvannucchi@unifi.it.

Publikováno v: Pathology, research and practice [Pathol Res Pract] 2024 Nov; Vol. 263, pp. 155648. Date of Electronic Publication: 2024 Oct 09.